Real World Perspective: Evidence Shaping the Treatment of Severe Keratitis in Dry Eye Disease (Western Australia)
Date: 20/03/2023 (AWST)
Venue: Quality Hotel Lighthouse, Bunbury, WA, 6230
Provider: CSL Seqirus
Contact: Daniel Yu, [E] daniel.yu@seqirus.com, [P] 0427 769 539
Learning Objectives
- Understand how to escalate treatment in patients with dry eye disease with severe keratitis with ciclosporin eye drops.
- Gain insight into the relevance of real-world evidence to help guide the practical management of patients with ciclosporin eye drops, specifically Ciclosporin 0.1% eye drops.
- Know the pathways for applying for PBS Authority application for Ikervis (ciclosporin 0.1% eye drops), where eligible.
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| Introduction, Update on Ikervis® and Case Studies |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| PERSPECTIVE Study: Real-World Evidence of Ikervis® effectiveness, tolerability and safety |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Live Q&A: Real World Insights |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |